This inventor holds 1 USPTO granted patent. Top assignee: National Technology & Engineering Solutions of Sandia, LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Christopher Sumner: Innovator in Brain-Targeting Antibodies
Introduction
Christopher Sumner is a notable inventor based in Livermore, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for medical applications. His work focuses on creating single domain antibodies that can effectively target the brain.
Latest Patents
Sumner holds a patent for "Brain-targeting single domain antibodies and purification methods." This patent describes single domain antibodies (sdAbs) that are specifically designed to pass through the blood-brain barrier in humans and mammals. The patent outlines methods for using these sdAbs, including their ability to bind to brain cells, transport other beneficial sdAbs, and deliver biochemical or pharmaceutical agents for treating various diseases and conditions.
Career Highlights
Christopher Sumner is currently employed at National Technology & Engineering Solutions of Sandia, LLC. His role at this esteemed organization allows him to work on cutting-edge research and development projects that aim to improve healthcare outcomes through innovative technologies.
Collaborations
Sumner collaborates with talented professionals in his field, including Brooke Nicole Harmon and Jennifer Lauren Schwedler. These partnerships enhance the research and development process, leading to more effective solutions in biotechnology.
Conclusion
Christopher Sumner's work in developing brain-targeting antibodies represents a significant advancement in medical technology. His innovative approach has the potential to transform the treatment of neurological conditions and improve patient outcomes.